A Two-Step Process for Thymic Regulatory T Cell Development  by Lio, Chan-Wang Joaquim & Hsieh, Chyi-Song
Immunity
ArticleA Two-Step Process for Thymic
Regulatory T Cell Development
Chan-Wang Joaquim Lio1 and Chyi-Song Hsieh1,*
1Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110, USA
*Correspondence: chsieh@im.wustl.edu
DOI 10.1016/j.immuni.2007.11.021SUMMARY
Recognition of self-antigens is required for regula-
tory T (Treg) cells to exert dominant tolerance. How-
ever, the mechanism by which self-reactive thymo-
cytes are diverted into the Treg cell subset is
unclear. To address this question, we looked for
the immediate precursors to Treg cells within
Foxp3CD4+CD8 thymocytes. By using intrathymic
transfer, we found that the CD25hi subset is highly
enriched in Treg cell precursors. This was supported
by tracking of thymocyte development via analysis of
T cell receptor (TCR) repertoires in a TCR-b trans-
genicmodel. These Treg cell precursors exist at a de-
velopmental stage where they are poised to express
Foxp3 without further TCR engagement, requiring
only stimulation by interleukin-2 (IL-2) or IL-15.
Thus, we propose that the selection of self-reactive
thymocytes into the Treg cell subset occurs via an
instructive rather than stochastic-selective model
whereby TCR signals result in the expression of prox-
imal IL-2 signaling components facilitating cytokine-
mediated induction of Foxp3.
INTRODUCTION
Natural regulatory T (Treg) cells play an important role in the
preservation of self-tolerance (Fontenot and Rudensky, 2005; Iz-
cue et al., 2006; Sakaguchi, 2004). Although there are both CD8+
and CD4+Foxp3+ cells, here, we use ‘‘Treg cell’’ in the tradition-
ally defined manner to indicate CD4+Foxp3+, and mostly CD25+,
cells. Genetic ablation of Treg cell development resulting from
Foxp3 deficiency leads to overwhelming autoimmunity and early
death in both humans (Bennett et al., 2001) and mice (Fontenot
et al., 2003). Moreover, acute depletion of Foxp3-expressing
cells turns a normal resting immune system into one that is hy-
peractive and uncontrolled, resulting in the death of an adult an-
imal within a mere 10 days (Kim et al., 2007; Lahl et al., 2007).
Thus, Treg cells are required throughout life to preserve immune
homeostasis.
A characteristic feature of Treg cells is their ability to recognize
self-antigens (Apostolou et al., 2002; Jordan et al., 2001; Seddon
and Mason, 1999; Taguchi et al., 1994). This is consistent with
the finding that the TCR repertoires of Treg and non-Treg cells
are different with a small degree of overlap (Hsieh et al., 2004,
2006; Pacholczyk et al., 2006; Wong et al., 2007). Importantly,100 Immunity 28, 100–111, January 2008 ª2008 Elsevier Inc.self-reactivity appears to be required for Treg cells to maintain
self-tolerance and prevent autoimmunity in TCR transgenic
and nontransgenic models (Samy et al., 2006; Seddon and
Mason, 1999; Taguchi et al., 1994; Tang et al., 2004).
Although it is commonly accepted that Treg cell development
predominantly occurs in the thymus (Hsieh et al., 2006; Itoh et al.,
1999; Pacholczyk et al., 2006; Wong et al., 2007), the mecha-
nisms by which this occurs remain controversial. Monoclonal
TCR transgenic studies suggested that thymic encounter with
‘‘self-antigen’’ expressed as a second transgene facilitates
Treg cell development (Apostolou et al., 2002; Jordan et al.,
2001). A report with a different ab-TCR, however, argued that
the relative increase in the Treg cell subset was due to preferen-
tial deletion of non-Treg cells bearing self-reactive TCRs, favor-
ing a stochastic-selective, rather than instructive, model (Van
Santen et al., 2004).
Cytokines, primarily IL-2, have also been suggested to play
a role in thymic Treg cell development. IL-2Rb (CD122)-deficient
mice exhibit a decreased number of thymic Treg cells (Bayer
et al., 2007; Burchill et al., 2007; Malek et al., 2002). However,
other studies have argued that IL-2 is not critical for thymic
Treg cell development, because IL-2-deficient mice have only
a 50% decrease in thymic Treg cell numbers (D’Cruz and Klein,
2005; Fontenot et al., 2005b).
Finally, a recent report has suggested that unknown trans-act-
ing factors that act on ‘‘double-negative’’ CD4–CD8– cells, which
have not yet expressed TCR, play an important role in the pro-
cess of thymic Treg cell development (Pennington et al., 2006).
How these factors might skew certain TCRs into the Treg subset
is unclear. This model has recently attracted proponents based
on the report that non-self-, rather than self-, antigens represent
the cognate antigens of Treg cells (Pacholczyk et al., 2007).
Thus, the developmental steps that divert thymocytes into the
Treg cell subset, and the relationship of those steps to TCR
specificity and cytokines, remain ill defined and controversial.
We reasoned that the study of thymic Treg cell differentiation,
like any other developmental system, would be greatly simplified
by the in vivo identification of an intermediate in this process, i.e.,
a Treg cell precursor. Although many cells may be considered
precursors, including the aforementioned double-negative cells
(Pennington et al., 2006), we were interested in cells that are
closer in the developmental program to expressing Foxp3, the
best available marker for Treg cells (Fontenot et al., 2005c).
Other studies have examined cells that were induced to express
Foxp3 but were unable to make functional protein (Gavin et al.,
2007; Lin et al., 2007). Although these studies are important in
addressing the contribution of Foxp3 to the Treg cell phenotype,
they shed little light regarding the mechanisms that actually
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Foxp3–CD4+CD8– (CD4SP) thymocytes are observed prior to
the appearance of Foxp3+ cells in the neonatal period (Fontenot
et al., 2005a). Although it was suggested that these cells may be
Treg cell precursors, this was not experimentally demonstrated.
Thus, the developmental destination of the CD25hi cells is un-
known, because these cells could alternatively become nega-
tively selected (Kishimoto et al., 1995) or exported into the
periphery.
Based on this study (Fontenot et al., 2005a) and our own ob-
servations, we formally tested whether the CD25hiFoxp3–
CD4SP subset contained Treg cell precursors. We found that
this subset was highly enriched in cells that express Foxp3 after
intrathymic transfer. Surprisingly, these Treg cell precursors ap-
peared to be at a penultimate step in Treg cell differentiation, re-
quiring only non-TCR-derived signals to express Foxp3 in vivo
and a minimal quantity of IL-2 in vitro. Because the ability of IL-2
to induce Foxp3 correlated with the ability to detect proximal
IL-2 signaling, we propose that Treg cell development occurs
via an instructive, rather than stochastic-selective, model
whereby self-reactive thymocytes upregulate components of
the proximal IL-2 signaling pathway to compete for cytokine-
mediated induction of Foxp3.
RESULTS
Identification of Treg Cell Precursors
within the CD25hiFoxp3– CD4SP Subset
To address the mechanism of thymic Treg cell differentiation, we
asked whether there are definable intermediates in this develop-
mental program. Because the vast majority of Foxp3+ T cells ap-
pear at the CD4+CD8– stage (Fontenot et al., 2005c), we focused
on understanding Treg cell development in this subset. For this
report, we have utilized Foxp3gfp reporter mice to measure
Foxp3 expression (Fontenot et al., 2005c). By using a variety of
phenotypic markers, we were struck by the overlap in GITR
and CD25 expression between the Treg cells and a subset of
Foxp3– CD4SP thymocytes (Figure 1A). Of note, both GITR
and CD25, the IL-2 receptor a chain, have been used as markers
for Treg cells. This CD25hi population also arises in the neonatal
period immediately prior to the development of Foxp3+ thymo-
cytes (Fontenot et al., 2005a) and is greatly diminished in TCR
transgenic 3 Rag2-deficient mice that harbor few, if any, Treg
cells (Apostolou et al., 2002). The CD25hiGITRhi subset repre-
sents approximately 3% of CD4SP and 0.2% of all thymocytes.
The low frequency of these cells required magnetic bead deple-
tion of CD8+ cells followed by flow cytometric sorting of an
approximately 1% target population. To test whether thymic
subsets were enriched for precursors to Treg cells, we per-
formed intrathymic transfer to assess the frequency of cells
that upregulated the expression of Foxp3. For these in vivo ex-
periments, we avoided the use of anti-GITR DTA-1 monoclonal
antibody because of its potentially activating properties in vivo
(Shimizu et al., 2002). Three days after intrathymic transfer, we
found that on average, 13.8% of purified CD25hiFoxp3– CD4SP
cells acquired Foxp3 expression after 3 days, in contrast to
0.05% of CD25lo cells—a 280-fold enrichment (Figure 1B). This
was not a transient increase in Foxp3 expression, because we
observed that the percentage of Foxp3+ cells was stable 14days after intravenous adoptive transfer (Figure 1C). Thus, the
CD25hiFoxp3– CD4SP thymocyte subset is enriched for Treg
cell precursors.
We then performed an extensive flow cytometric analysis of
the CD25hiFoxp3– subset (Figure 1D; see Figure S1 available on-
line). We found that the CD25hi cells were TCR-bhi, suggesting
that these cells have undergone positive selection. Consistent
with the proposed developmental progression, CD25hi cells ap-
peared more immature than Treg cells based on their higher ex-
pression of HSA (heat stable antigen). In contrast with CD25 and
GITR, other Treg cell markers such as FR4 and CD103 were not
elevated in the CD25hi subset, and potentially may represent
Foxp3-induced markers. However, CD69 and CD44 were upre-
gulated. Along with the increased expression of CD25 and GITR,
these data suggest that CD25hiFoxp3– CD4SP cells represent
a thymocyte subset that has recently been activated through
the TCR.
Treg TCRUsagewithin the Foxp3–CD25hi CD4SP Subset
The notion that TCR stimulation may be responsible for the gen-
eration of CD25hi cells is consistent with several studies with
polyclonal TCR models that have uniformly shown that the
Treg TCR repertoire is different from, but overlapping with, the
non-Treg TCR repertoire in the thymus (Hsieh et al., 2006; Pa-
cholczyk et al., 2006; Wong et al., 2007). However, it is unclear
whether TCR-derived signals played a direct role in the develop-
mental process resulting in the induction of Foxp3, or whether it
acted in a circumstantial fashion by favoring the negative selec-
tion of self-reactive Foxp3– versus Foxp3+ cells (Van Santen
et al., 2004). In fact, it has been argued that TCR specificity to
self-antigen plays little to no role in thymic Treg cell development
(Pacholczyk et al., 2007), implying that the cell-surface pheno-
type consistent with TCR activation may be a stochastic and an-
tigen-nonspecific occurrence. We therefore asked whether the
population of Treg cell precursors within the CD25hi CD4SP sub-
set arose because of TCR specificity characteristic of Treg, and
not non-Treg, cells. To test this, we utilized a fixed TCR-b model
for tracking the developmental fate assigned to individual TCRs
(Hsieh et al., 2004, 2006). We purified T cells from the Foxp3+
Treg, and CD25hiGITRhi and CD25loGITRintFoxp3– CD4SP sub-
sets, and we sequenced TRAV14 (Va2) chains as previously de-
scribed (Hsieh et al., 2006). GITRlo CD4SP cells were excluded
because they appear to be immature thymocytes that are transit-
ing to either CD4SP or CD8SP cells (data not shown). We found
that the thymic Treg TCR repertoire was more similar to the
CD25hiGITRhi subset than the CD25loGITRint subset (Figure 2A;
Figure S2), consistent with the notion that the Treg cell precur-
sors in the CD25hiFoxp3– subset have already been selected
based on TCR specificities characteristic of mature Foxp3+
Treg cells. The enrichment of Treg TCRs in the CD25hi subset
is in agreement with our previous observation that the CD25hi
subset is enriched in functional Treg cell precursors (Fig-
ure 1B). We did not expect that the CD25hiFoxp3– CD4SP subset
would share the exact same TCR repertoire as Foxp3+ cells
because a large proportion of the CD25hi subset did not develop
into Treg cells (Figure 1B). Similar to our previous results (Hsieh
et al., 2006), the TCR repertoire of the CD25loGITRint CD4SP
subset was different from that of the Treg cell subset with a small
degree of overlap. We also compared the TCR repertoires fromImmunity 28, 100–111, January 2008 ª2008 Elsevier Inc. 101
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(Foxp3–CD44lo), and memory or activated (Foxp3–CD44hi)
CD4+ cells. In accordance with our observations between thymic
data sets, we also found that the thymic CD25hi
GITRhi, in comparison with the CD25loGITRint subset, showed
greater usage of TCRs found in peripheral Treg cells (Figure 2B).
This TCR tracking study therefore suggests that the Treg cell
precursors within the CD25hi subset are generated due to TCR
specificities characteristic of Treg cells.
A TCR-Independent Phase of Thymic Treg
Cell Development
Although it appeared that TCR specificity is important for the
generation of Treg cell precursors, it was still possible that addi-
tional TCR signals are required to complete the process of Treg
cell differentiation. To directly address this issue, we intrave-
nously transferred CD25hiFoxp3– thymocytes into MHC class
II-deficient (H-2DAb1-Ea) or MHC class II-sufficient ab-T cell-102 Immunity 28, 100–111, January 2008 ª2008 Elsevier Inc.deficient (Tcrb–/–) hosts. We observed that regardless of MHC
class II expression in the host, a similar frequency of adoptively
transferred CD25hi CD4SP thymocytes acquired Foxp3 3 days
after transfer (Figure 3). By contrast, the small frequency of
CD25lo cells that became Foxp3+ in an MHC class II-sufficient
host was essentially abrogated in an MHC class II-deficient
host, supporting the notion that CD25lo thymocytes are at an ear-
lier stage in Treg cell development requiring TCR-derived
signals. Taken together, these data suggest that TCR-derived
signals are involved prior to, or at the time of, development of
Treg cell precursors within the CD25hiFoxp3– subset. Impor-
tantly, once that developmental stage is achieved, further devel-
opment is independent of TCR-derived signals.
IL-2 Is Sufficient for Foxp3 Induction In Vitro
The observation that deletion of the common g-chain of the IL-2
receptor completely inhibited the development of thymic Treg
cells (Fontenot et al., 2005b) suggested that cytokines may beFigure 1. CD25hiFoxp3– CD4SP Thymocytes
Are Enriched for Treg Cell Precursors
(A) Overlap between Foxp3+ and Foxp3– CD4SP
thymocytes for the expression of CD25 and
GITR. Thymocytes from Foxp3gfp reporter mice
were analyzed by flow cytometry. Cells are gated
on the CD4SP subset and are further gated based
on Foxp3 (left) into the Foxp3– (middle) and Foxp3+
subsets (right).
(B) Development of Foxp3+ cells from CD25hi, but
not CD25lo, Foxp3– CD4SP cells after intrathy-
mic transfer. FACS purified CD25lo or CD25hi
Foxp3–CD45.2+ CD4SP cells (105) were intra-
thymically injected into congenically marked
CD45.1+ recipients. Development of Foxp3+ cells
was analyzed by flow cytometry 3 days after
transfer. Representative FACS plots for the intra-
thymically injected CD45.1–CD45.2+ CD4SP cells
from two independent experiments are shown
on the top, and the percent Foxp3+ cells from in-
dividual mice is plotted on the bottom. The mean
value is indicated by a bar.
(C) Maintenance of Foxp3+ cells from CD25hi
Foxp3– CD4SP thymic precursors. 105 sorted
CD25lo or CD25hiFoxp3–CD4SP thymocytes
(Thy1.2+) together with 53 105 MACS purified pe-
ripheral CD4+ cells (Thy1.1+) were intravenously
transferred into TCR-b-deficient mice and ana-
lyzed at 3 and 14 days by flow cytometry of pooled
spleen and lymph nodes cells. Representative
FACS plots from two independent experiments
show cells gated on donor Thy1.2+Thy1.1–
TCR-b+CD4+ cells.
(D) Flow cytometric characterization of CD25hi
Foxp3– CD4SP cells. Thymocytes from Foxp3gfp
mice were stained with the indicated antibodies
along with CD4, CD8, and CD25, and analyzed
on a FACSAria. Histogram plots shown are gated
on CD4SP cells and as indicated in the legend on
the right.
The numbers in the FACS plots represent the per-
centage of cells in the corresponding gate.
Immunity
Two-Step Process for Thymic Treg Cell DevelopmentTCR-independent factors for Treg cell development. We there-
fore tested whether freshly isolated thymocytes would upregu-
late Foxp3 in response to exogenous cytokines. We observed
that IL-2 induced Foxp3 in 25.5% (±4.8 SD) of purified CD25hi
GITRhi CD4SP cells by 24 hr (Figures 4A and 4B). This in vitro per-
centage is approximately twice the percentage of Foxp3+ cells
observed after in vivo transfer (Figure 1B), suggesting that the
amount of cytokine may be limiting in vivo. By contrast, only
0.6% (±0.2 SD) of purified CD25loGITRint CD4SP thymocytes up-
regulated Foxp3 in response to IL-2. Consistent with the notion
that this is a TCR-independent phase of Treg cell development,
addition of plate-bound anti-CD3 did not markedly increase the
frequency of Foxp3+ cells in the presence or absence of IL-2
(Figure 4C; Figure S3). CD25hi cells that upregulated Foxp3
were suppressive in vitro, suggesting that they have acquired
functional characteristics of Treg cells (Figure 4D). Thus, the ad-
ministration of a single cytokine to precursors within the CD25hi
subset is sufficient for inducing Foxp3, the final step in Treg cell
development (Gavin et al., 2007).
The enrichment of Treg cell precursors within the CD25hi
CD4SP thymocytes subset suggested that the presence of
CD25 may facilitate the induction of Foxp3. We sorted four
Foxp3– thymocyte subsets with varying expression of CD25
and GITR, three of which (denoted a, b, and c in Figure 4E)
were in areas of overlap between the Foxp3+ and Foxp3– sub-
sets. Consistent with the hypothesis that IL-2 signaling plays
a role in Foxp3 acquisition, we found that the amount of CD25
correlated with the frequency of cells that upregulate Foxp3 in
response to IL-2.IL-2 and IL-15 Are the Common g-Chain Cytokines
that Induce Foxp3
An alternative explanation for the above results is that IL-2, in-
stead of directly inducing Foxp3 expression, may simply permit
the expansion or survival of thymocytes precommitted to be-
coming Treg cells. We first assessed whether IL-2 induced the
proliferation of CD25hi cells that become Foxp3+. Because
CFSE interfered with the use of Foxp3gfp as a Treg cell marker,
we used the fluorescent dye DDAO-SE to track cell proliferation
via its dilution. We observed essentially no decrease in DDAO-SE
staining during our 24 hr short-term IL-2 culture, though the in-
duction of Foxp3 was easily visualized (Figure 5A). Next, we per-
formed real-time quantitative RT-PCR for Foxp3 to evaluate time
points that could not be easily visualized by flow cytometry be-
cause of the time required for protein folding of GFP for fluores-
cence (Figure 4B). We observed that IL-2 rapidly induced Foxp3
mRNA by 3 hr (Figure 5B). Importantly, delay of IL-2 administra-
tion by 3 hr did not negatively affect the induction of Foxp3
mRNA, arguing that IL-2 is not simply a survival or growth factor
allowing the expression of Foxp3 via a preprogrammed path, but
that IL-2 directly induces the expression of Foxp3 in Treg cell
precursors.
Because a deficiency in the common g-chain, and not IL-2, re-
sults in a virtual absence of thymic Treg cells (Fontenot et al.,
2005b), we also tested the ability of other common g-chain cyto-
kines to induce Foxp3 in CD25hi CD4SP thymocytes (Figure 5C).
Of the cytokines tested, only IL-2 and IL-15 were effective in in-
ducing Foxp3 expression in a high proportion of CD25hi cells.
However, the in vitro potency of these two cytokines for inducingFigure 2. The CD25hiFoxp3– CD4SP TCR
Repertoire Is Enriched for Treg TCRs
(A) Analysis of shared TCR-a sequences among
thymic CD4SP populations. Foxp3+, CD25hiGITRhi
Foxp3–, or CD25loGITRintFoxp3–, CD4SP thymo-
cytes were sorted from TCli TCR-b transgenic 3
Foxp3gfp 3 Tcra+/– mice and TRAV14 (Va2) TCR-
a sequences obtained as previously described
(Hsieh et al., 2004). Data shown are pooled from
two independent experiments (Figure S2). Each
pie graph represents the TCR-a sequences in the
data set that were also found in at least one other
thymic data set. The portion of the TCR-a se-
quences that overlaps another data set is indi-
cated by a different color in the pie graph, and
the data set overlapped is denoted by an arrow.
The number of TCR-a chains that were not found
in another subset was similar between the three
subsets (73%, 65%, and 67% for CD25lo, CD25hi,
and Foxp3+ subsets, respectively).
(B) Comparison of TCR-a sequences from thymic
and peripheral subsets. Unique TCR-a sequences
from the indicated thymic CD4SP subsets that
were also found in the peripheral TCR data sets
are plotted on the x axis. Each vertical bar
represents the likelihood that an individual thymic
TCR would be found within the peripheral
Foxp3+, naive (Foxp3–CD44lo), or memory or acti-
vated (Foxp3–CD44hi) CD4+ T cell data sets. The
size of each color in the bar is calculated by the fre-
quency of the TCR in the subset divided by the sum
of the frequencies in all three subsets.Immunity 28, 100–111, January 2008 ª2008 Elsevier Inc. 103
Immunity
Two-Step Process for Thymic Treg Cell DevelopmentFoxp3 expression differed by at least 50-fold (Figure 5D), al-
though in trans presentation may enhance the potency of IL-15
in vivo (Burkett et al., 2004). It should be noted that these data
may underestimate the true sensitivity of the Treg cell precursors
to IL-2 induction because of our inability to purify the CD25hi sub-
set without the use of monoclonal antibodies to CD25, which in-
hibit IL-2 signaling. Nevertheless, the dose of IL-2 required to
achieve 15% induction of Foxp3 expression, the amount ob-
served after intrathymic transfer, was only 75 pg/ml. This repre-
sents a molar concentration of 4.4 pM, which is in the 10 pM Kd
range of the high-affinity IL-2Rabg receptor (Sharon et al., 1986).
In vitro blockade of IL-2 did not reveal a role for endogenous pro-
duction of IL-2 (Figure S4). Although TGF-b has been suggested
to be important for the development of Foxp3+ cells from periph-
eral T cells in vitro (Chen et al., 2003), we did not observe a role
for TGF-b in our in vitro thymocyte assay (Figure S5), consistent
with in vivo observations from conditional T cell knockouts of
Figure 3. A Subset of CD25hi CD4SP Thymocytes Is at a TCR-
Independent Stage of Treg Cell Development
Purified CD25lo or CD25hiFoxp3– CD4SP thymocytes (CD45.1+Thy1.2+, 105)
were intravenously transferred along with 5 3 105 peripheral MACS-purified
CD4+ cells (CD45.2+Thy1.1+) into either TCR-b-deficient or MHC class II-defi-
cient mice (CD45.2+Thy1.2+). Development of Foxp3+ T cells from the thymo-
cyte population was assessed 3 days after transfer by flow cytometry. FACS
plots are representative of two independent experiments and are gated on
CD45.1+CD45.2–CD4+ cells. Percentage of cells that are Foxp3+ are plotted
below and shown as mean ± SD (n = 3–4). The numbers in the FACS plots rep-
resent the percentage of cells in the corresponding gate.104 Immunity 28, 100–111, January 2008 ª2008 Elsevier Inc.TGF-bRII (Li et al., 2006; Marie et al., 2006). From these data,
we conclude that IL-2 and IL-15 are the predominant common
g-chain cytokines responsible for induction of Foxp3 in CD25hi
Treg cell precursors.
Regulation of Proximal IL-2 Signaling during theProcess
of Treg Cell Development
The ability of cytokines to induce Foxp3 in CD25hi Treg cell pre-
cursors but not CD25lo cells could be due to a differential ability
of those cells to respond at the level of proximal signaling. Be-
cause Janus kinase-1 (Jak1)- and Jak3-STAT5 is the main sig-
naling pathway that is activated by IL-2, we determined whether
Jak kinase activity is required for the induction of Foxp3. Indeed,
pharmacologic inhibition of Jak kinase activity prevented the ex-
pression of Foxp3 (Figure 6A). Thus, Jak kinase activation, pre-
sumably via STAT5, is required for the induction of Foxp3 in
Treg cell precursors.
It has previously been reported that STAT5 is required for the
development of Treg cells, because STAT5a3 STAT5b-double-
deficient mice are greatly diminished in Treg cell numbers
(Burchill et al., 2007; Yao et al., 2007). We therefore analyzed
the activation status of STAT5 via intracellular staining of phos-
phorylated STAT5 (Figure 6B). Interestingly, the response of
CD25hi cells to IL-2 is biphasic, as indicated by the fact that ap-
proximately half of the cells induced phospho-STAT5 after IL-2
stimulation. By contrast, CD25lo cells, which contain few Treg
cell precursors, uniformly generated little if any phospho-
STAT5 in response to IL-2. The ability of IL-2 to induce phos-
pho-STAT5 may be a feature of Treg cell development, because
Foxp3+ cells are broadly capable of inducing phospho-STAT5.
Curiously, addition of IL-7 resulted in an appreciable induction
of phospho-STAT5, but not Foxp3, in CD25lo cells (Figures 4A
and 6B), suggesting that activation of STAT5 alone is insufficient
to facilitate Foxp3 expression and that additional factors are re-
quired for the development of cytokine-responsive Treg cell pre-
cursors. The ability to respond to IL-7 is downregulated in the
CD25hi and Treg subsets, implying a greater role for other cyto-
kines such as IL-2 for the generation of phospho-STAT5 during
Treg cell development. Because intracellular staining precludes
further analysis of the thymocytes, we could not directly prove
that the cells capable of inducing phospho-STAT5 do upregulate
Foxp3. Nevertheless, the relative absence of detectable proxi-
mal IL-2 signaling in CD25lo cells and in some of the CD25hi cells
suggests that differential regulation of the proximal IL-2 signaling
machinery plays an important role in the thymic development of
Foxp3+ cells from Treg cell precursors.
STAT5 Induction Is Not Sufficient to Induce
Foxp3 in CD25hi CD4SP Cells
Because our analysis has thus far addressed only the expression
of CD25, the a chain of the trimeric high-affinity IL-2Rabg, it was
possible that other proximal IL-2 components may be missing in
the CD25hi cells unable to induce phospho-STAT5. Because the
common g-chain is considered to be constitutively expressed,
we assessed the expression of CD122 (IL-2Rb) on the CD25hi
Foxp3– subset (Figure 7A). Because only one-third of CD25hi
cells expressed high amounts of CD122, it was possible that
CD122 expression correlated with the ability to induce phos-
pho-STAT5 in response to IL-2. We found that almost all sorted
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whereas only 30% of CD25hiCD122lo cells did so (Figure 7B). The
ability to induce phospho-STAT5 correlated with the ability to in-
duce Foxp3 after 24 hr of culture (Figure 7C). Because 90% of
CD25hiCD122hi cells could signal via STAT5 but only half were
capable of inducing Foxp3 expression, this lends further support
to the notion that other factors are required in concert with IL-2-
derived signals to induce Foxp3. One intriguing possibility is that
cytokine signaling itself may be involved in generating this un-
known factor, because IL-2 could still induce Foxp3 in some of
the CD25hiFoxp3– cells that did not upregulate Foxp3 after the
first 24 hr IL-2 stimulation (Figure S6). Thus, we propose that
the generation of the cytokine-responsive Treg cell precursor re-
quires the induction of an unknown factor that permits Foxp3
expression, in concert with the upregulation of the proximal
IL-2 signaling machinery.
Although not absolute, the clear shift from IL-7 to IL-2 signaling
between CD25lo and CD25hiFoxp3– cells suggested that CD127
(IL-7Ra) may be downregulated during the process of thymic
Treg cell development. Indeed, the upregulation of CD122 inCD25hi cells was associated with a decrease in CD127 expres-
sion (Figure 7D). We then sorted subsets of CD25hi cells based
on CD122 and CD127 expression and assessed the ability of
IL-2 to induce Foxp3. We found that the expression of CD127
marked a subpopulation of CD25hi cells that have a low fre-
quency of cytokine-responsive Treg cell precursors (Figure 7E).
Although further studies are required, these data suggest that
Treg cell development within the CD25hi subset may be pheno-
typically described by the downregulation of CD127 followed by
the upregulation of CD122.
DISCUSSION
The observation that a subset of CD25hiFoxp3– CD4SP thymo-
cytes contains precursors for natural Treg cells has enabled us
to generate a framework for thymic Treg cell development. Tem-
porally, our data suggest that this process can be divided into at
least two distinct stages based on the requirement for TCR-
derived signals. The initial TCR-dependent generation of Treg
cell precursors in the CD25hi subset is based on the observationFigure 4. Cytokine-Mediated Induction of
Foxp3 in CD25hiFoxp3– CD4SP Thymocytes
(A) IL-2 is sufficient to induce Foxp3 in Treg cell
precursors in vitro. Sorted CD25lo or CD25hi
Foxp3– CD4SP cells were cultured as described
in the Experimental Procedures and analyzed at
24 hr for Foxp3 expression by flow cytometry.
(B) Time course of Foxp3 induction by IL-2. Puri-
fied CD25hiFoxp3– CD4SP thymocytes were
cultured with indicated combinations of IL-2 and
IL-7 and analyzed for Foxp3 expression by flow
cytometry at 12, 24, and 48 hr.
(C) TCR stimulation plays little role in the induction
of Foxp3 from CD25hi cells. Purified CD25hiFoxp3–
CD4SP cells were labeled with DDAO-SE and
then cultured in IL-2 and plate-bound anti-CD3
(10 mg/ml) as indicated. Expression of Foxp3 and
dilution of DDAO-SE were assessed by flow cy-
tometry at 24 hr.
(D) Cells induced to express Foxp3 by IL-2 are sup-
pressive in vitro. Purified CD25hiFoxp3– CD4SP
thymocytes (Thy1.2+) were cultured with IL-2 for
24 hr. Cells that upregulated Foxp3 were purified
by FACS (bottom) and cocultured with freshly
FACS-purified peripheral CFSE-labeled CD25–
CD4+ effector T cells (Thy1.1+), 1 mg/ml anti-CD3,
and irradiated splenic APCs, in the absence of ex-
ogenous cytokines. CD25loFoxp3– (middle) and
Foxp3+ CD4SP thymocytes (top) cultured 24 hr in
vitro with IL-2 were used as controls. Three days
after stimulation, effector T cell proliferation was
analyzed by CFSE dilution in the Thy1.1+CD4+
T cell population shown. The numbers in the plots
are the mean percentages ± SD from duplicate
wells in the gate drawn.
(E) CD25 expression correlates with the ability for
IL-2 to induce Foxp3. The four Foxp3– CD4SP pop-
ulations (a, b, c, and d) were sorted and cultured
with IL-2 as described. Post-sort analysis is shown
in Figure S8.
Data shown represent 2 (B–E) or 5 (A) independent
experiments. The numbers in the FACS plots rep-
resent the percentage of cells in the corresponding
gate.Immunity 28, 100–111, January 2008 ª2008 Elsevier Inc. 105
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Two-Step Process for Thymic Treg Cell Developmentthat this subset is enriched in TCRs normally found in the Treg
cell subset. Alterations in the TCR repertoire in the CD25hi subset
could result from stochastic-selective or instructive TCR-derived
signals. We favor the latter because ab-TCR transgenic mice on
a Rag-deficient background, which do not develop Treg cells,
are also deficient in this CD25hi population (Apostolou et al.,
2002). Furthermore, upregulation of CD25 and CD69 has long
been associated with TCR activation (Kishimoto and Sprent,
1997), supporting the notion that generation of CD25hi cells is
a TCR-instructive event.
The direct involvement of TCR signaling in this model is in clear
contrast with a recent report suggesting that Treg cells do not
display increased avidity toward self-antigens (Pacholczyk
et al., 2007). Their observation that Treg TCRs do not show
strong activation to self-antigens on splenic APCs is consistent
with our previously published report, where we suggested that
the avidity of the majority of Treg TCRs for self ligands is below
the range characteristic of conventional T cell responses (Hsieh
et al., 2004). It is unclear whether hybridoma cell lines generated
without prior immunization would be sufficiently sensitive to test
this possibility. Their suggestion that the overlap between Treg
and non-Treg TCRs is greater when assessed in the absence106 Immunity 28, 100–111, January 2008 ª2008 Elsevier Inc.of frequency information does not, in our opinion, imply that
TCR specificity is not important, but rather that control of Treg
development by TCR specificity is not absolute, but probabilistic
(Hsieh et al., 2004). When the frequency of each TCR is taken into
account, their data, like ours and others (Hsieh et al., 2004, 2006;
Wong et al., 2007), clearly demonstrate that the TCR repertoires
of Treg and non-Treg cells differ, as shown by the fact that many
TCRs are preferentially found in one or the other subset. Al-
though we cannot formally exclude a TCR-independent event
that selectively upregulates CD25 on a subset of T cells that ex-
presses a different (but overlapping) set of TCRs, we believe that
the simplest interpretation is that the CD25hi subset is generated
because of moderate avidity TCR interaction with self-antigens
below or around the threshold for negative selection.
Other molecules may also play a role in the TCR-dependent
phase. Mice deficient in the TCR costimulator CD28 show a di-
minished number of Treg cells (Salomon et al., 2000). Further
studies have found that CD28 provides a cell-intrinsic signal in-
dependent of its ability to promote cell-extrinsic signals such
as IL-2 (Tai et al., 2005), suggesting that CD28 acts, in part, dur-
ing the TCR-dependent phase of Treg cell development. Cyto-
kines may also be involved in this TCR-dependent stage,Figure 5. Characterization of Foxp3 Induction by Common g-Chain Cytokines
(A) Induction of Foxp3 is not associated with cell proliferation. Purified CD25lo or CD25hiFoxp3–, and Foxp3+ CD4SP cells were labeled with DDAO-SE and cul-
tured for 24 hr. Dilution of DDAO-SE and acquisition of Foxp3 was assessed by flow cytometry. DDAO-SE staining after proliferation is shown in Figure S3. The
numbers in the FACS plots represent the percentage of cells in the corresponding gate.
(B) Rapid induction of Foxp3 mRNA by IL-2. Purified CD25hiFoxp3– CD4SP cells were cultured in the presence of 5 ng/ml murine IL-7 with or without 5 U/ml human
IL-2 for either 3 hr, or for the last 3 hr of a 6 hr culture, and assessed for Foxp3 mRNA expression by real-time RT-PCR normalized to HPRT expression (Hori et al.,
2003). For reference, freshly isolated Foxp3+ thymocytes express 3.6 normalized amount of Foxp3 mRNA. Data shown are mean ± SD (n = 3).
(C) Analysis of common g-chain cytokines for their ability to induce Foxp3. Sorted CD25hiFoxp3– CD4SP cells were assayed for Foxp3 induction at 24 hr with the
indicated murine cytokines (100 ng/ml) and IL-7 (5 ng/ml). Titration of cytokines down to 1 ng/ml did not enhance the percentage of Foxp3+ cells observed (data
not shown).
(D) IL-2 is more potent than IL-15 for the induction of Foxp3. Purified CD25hiFoxp3– CD4SP thymocytes were cultured with IL-7 and the indicated concentrations
of murine IL-2 or IL-15. Foxp3 expression was assessed by flow cytometry at 24 hr. Data are representative of two independent experiments. The difference in
potency between IL-2 and IL-15 was calculated with the concentration at half maximal Foxp3 induction.
Immunity
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decrease in CD25hiFoxp3– cells (Fontenot et al., 2005b). How-
ever, the proportion of those CD25hi cells that are Treg cell pre-
cursors is unknown, and additional studies are required.
After a period of TCR-dependent maturation, Treg cell devel-
opment enters a TCR-independent phase. Cells within this
phase are characterized by their ability to rapidly express
Foxp3 in vitro after exposure to IL-2 or IL-15 in the complete ab-
sence of antigen-presenting cells. The ability to upregulate
Figure 6. Upregulation of Proximal IL-2 Signaling Correlates with the
Ability to Induce Foxp3
(A) Foxp3 induction by IL-2 is Jak kinase dependent. Purified CD25hiFoxp3–
CD4SP cells were cultured in the presence of Jak inhibitor I or the carrier
(DMSO) only. Foxp3 expression was assessed by flow cytometry at 24 hr.
(B) CD25hi, but not CD25lo, Foxp3– CD4SP thymocytes are capable of gener-
ating proximal IL-2 signals. Purified cells were assessed for phospho-STAT5
induction as described in the Experimental Procedures. The shaded area
and solid line represent unstimulated and stimulated cells, respectively. Data
shown are representative of three independent experiments. The numbers in
the FACS plots represent the percentage of cells in the corresponding gate.Foxp3 correlates with the ability of the cell population to induce
phospho-STAT5 upon IL-2 stimulation, implying that a principle
component of the earlier TCR-dependent step is the upregula-
tion of the proximal IL-2 signaling pathway. However, it is likely
that TCR or other signals may generate other unknown factors
that render the Foxp3 promoter permissive to transcription after
IL-2-derived signals, because the ability to induce phospho-
STAT5 does not strictly equate with the ability to induce
Foxp3. In concert with this putative unknown factor, it seems
likely that the molecular mechanism by which IL-2 and IL-15 in-
duce Foxp3 is STAT5, which has binding sites within the Foxp3
promoter (Burchill et al., 2007; Yao et al., 2007).
Our in vitro data suggest that IL-2 plays a more prominent role
in Treg cell development than IL-15. This may be related to differ-
ences in receptor efficiencies, because CD25, but not IL-15Ra, is
markedly upregulated on Treg cell precursors (data not shown).
Although in trans presentation of IL-15 would enhance its signal-
ing in vivo, the notion that IL-2 plays a greater role than IL-15 in
Treg cell development is consistent with previous reports. For
example, IL-2- or CD25-deficient mice show impairment in thy-
mic Treg cell development, with approximately 50% of normal
Treg cell numbers in CD4SP thymocytes (Fontenot et al.,
2005b), and develop lymphoproliferative disease, whereas IL-
15-deficient mice show only a modest defect in Treg cell num-
bers and have no obvious autoimmunity (Burchill et al., 2007).
However, mice deficient in both IL-2 and IL-15 exhibit marked
deficiency in thymic Treg cell development (Burchill et al.,
2007). The most compelling evidence for the hierarchy of IL-2
over IL-15 is demonstrated by the observation that thymocytes
unable to express CD25 are 80% less competitive versus wild-
type thymocytes in developing Foxp3+ Treg cells in mixed
bone marrow chimeras (Fontenot et al., 2005b). These data sug-
gest that IL-15 or other cytokines compensate poorly for IL-2 in
a more natural environment than a full knockout animal. Taken
together, these data strongly suggest that IL-15 is not required
for thymic Treg cell development when IL-2 is present, but that
IL-15 can partially compensate when IL-2 is completely absent.
It appears that the source of IL-2 is likely to be T cells them-
selves, because bone marrow chimeras with IL-2-deficient do-
nors into wild-type hosts were phenotypically similar to that of
IL-2-deficient mice (Tai et al., 2005). Furthermore, they found
that IL-2 can exert its effect in a paracrine manner, as shown
by the fact that IL-2-deficient and sufficient thymocytes showed
equal expression of CD25 in a mixed bone marrow chimera. Al-
though the spontaneous production of IL-2 is difficult to observe
in situ, experimental induction of TCR activation in vivo sug-
gested that thymocytes undergoing apoptosis can release IL-2
(Bassiri and Carding, 2001).
Our data suggest that only a portion of CD25hi cells are cyto-
kine-responsive precursors to Treg cells. Based on our adoptive
transfer studies, it appears that many of the cells in the CD25hi
subset can survive as CD25lo non-Treg cells in the periphery.
The TCR tracking studies suggest that many TCRs thought to
be ‘‘non-Treg’’ cell associated can end up in the CD25hi subset.
Potentially, this could be due to weaker TCR-derived signals that
are sufficient to upregulate CD25, but not the rest of the proximal
IL-2 signaling machinery or other factors required for Foxp3 ex-
pression. Additionally, other unknown factors may be necessary
along with TCR signals to generate Treg cell precursors. WeImmunity 28, 100–111, January 2008 ª2008 Elsevier Inc. 107
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Two-Step Process for Thymic Treg Cell DevelopmentFigure 7. Ability to Signal via IL-2 Does Not Define the Cytokine-Responsive Treg Cell Precursor
(A) Biphasic expression of CD122 on CD25hiFoxp3– CD4SP thymocytes. The top histogram is gated on CD4SP cells. The bottom histogram represents the sort
gating for the CD25hiFoxp3– cells in the top and bottom quartiles of CD122 expression.
(B) Almost all CD122hiCD25hiFoxp3– cells have the capacity to signal via the IL-2 receptor. Analysis of phospho-STAT5 induced by IL-2 on the indicated cell sub-
sets was performed as described in the Experimental Procedures.
(C) Induction of Foxp3 does not correlate with the ability to signal via the IL-2 receptor. Sorted cells used in (B) were also stimulated with 50 U/ml human IL-2 and
5 ng/ml murine IL-7 to induce Foxp3 expression, which was analyzed by flow cytometry at 24 hr.
(D) Fractionation of the CD25hi subset with CD127 (IL-7Ra) and CD122 (IL-2Rb). Flow cytometric data shown are gated on the top labels and on CD4SP cells.
(E) Correlation of CD127 and CD122 with Treg cell precursor frequency in the Foxp3–CD25hi subset. CD25hiFoxp3– cells were purified on the basis of CD127 and
CD122 shown in (D) and stimulated with 5 ng/ml IL-7 and 50 U/ml human IL-2 for 24 hr. Data are representative of two independent experiments. The numbers in
the FACS plots represent the percentage of cells in the corresponding gate.108 Immunity 28, 100–111, January 2008 ª2008 Elsevier Inc.
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precursors within the CD25hi subset. Based on preliminary Affy-
metrix gene chip data from the CD25hi and CD25loFoxp3–
CD4SP populations, we tested a number of cell-surface markers
in conjunction with CD25 (data not shown). Addition of OX40,
CD83, ICOS, PD1, or 4-1BB did not improve our ability to identify
cytokine-dependent Treg precursors. Although we are continu-
ing to screen for other surface molecules, it may be an intracel-
lular marker that specifies the cytokine-responsive Treg cell
precursor.
An intriguing observation is that the number of cytokine-re-
sponsive CD25hi Treg cell precursor appears quite sizable,
representing approximately 25% of the Treg cell population
(one-quarter of CD25hi cells are cytokine responsive; the
Foxp3–CD25hi and Foxp3+ CD4SP subsets are of similar size).
Although the rates of Treg cell development and thymic export
are unknown, the presence of a large precursor population hints
at an in vivo bottleneck. This is supported by the finding that only
half of the cells capable of expressing Foxp3 as assessed in vitro
does so after in vivo transfer. Competition for limiting cytokines
may cause the bottleneck, thus promoting the preferential selec-
tion of Treg cells from thymocytes that express the highest
amount of CD25. If the expression of CD25 correlates with the
degree of TCR activation, and thus self-reactivity, this competi-
tion for IL-2 would provide additional selection pressure for
a more self-reactive Treg TCR repertoire. This is consistent
with the previously discussed results from mixed bone marrow
chimeras in which the CD25-deficient thymocytes were much
less competitive than CD25-sufficient cells (Fontenot et al.,
2005b). Further support for this hypothesis comes from the ob-
servation that the provision of tonic IL-2 signal during thymic de-
velopment via a transgenic constitutively active STAT5b skews
thymic Treg cell development to include many more T cells
that are normally destined to be non-Treg cells (Burchill et al.,
2008). CD25-mediated IL-2 signaling is therefore an important
process for selecting the self-reactive Treg TCR repertoire, as in-
dicated by the fact that bypassing it results in an expansion of the
Treg TCR avidity window for self-antigens into the realm nor-
mally reserved for positive selection of non-Treg cells.
The observation that TGF-b appears to be important for pe-
ripheral, but not thymic, Treg cell development suggests that
the two processes may be distinct (Chen et al., 2003). However,
we have found in preliminary studies that an analogous popula-
tion of cytokine-responsive Treg cell precursors exists in the pe-
riphery, albeit at a lower frequency. The peripheral CD25hi
Foxp3– subset may comprise both Treg cell precursors as well
as recently activated non-Treg effector cells. These initial results
suggest that although peripheral and thymic Treg differentiation
may require different initial signals, the latter stages may utilize
a common developmental pathway.
In summary, our observations favor an instructive model for
thymic Treg cell development that occurs in at least two sequen-
tial stages. We propose that TCR signaling results in the upregu-
lation of CD25 and other components of the proximal IL-2 signal-
ing pathway, and potentially a putative permissive factor for
Foxp3 expression. CD25 would offer competitive fitness for the
acquisition of IL-2, which would directly induce Foxp3 expres-
sion and finalize Treg cell development (Gavin et al., 2007). The
time required to complete this two-step process may explainthe historic observation that CD4SP cells can spend more than
a week in thymus. Thus, the relationship between TCR activa-
tion, IL-2R expression, and induction of Foxp3 by IL-2 may ex-
plain the apparent bias toward self-reactivity within the Treg
cell subset, enabling thymic Treg cell emigrants to enforce dom-
inant tolerance upon self-recognition in the periphery.EXPERIMENTAL PROCEDURES
Mice
Foxp3gfp reporter knockin and TCli TCR-b transgenic mice were kindly pro-
vided by A. Rudensky (U. Washington, Seattle, WA). MHC class II (H-2DAb1-Ea),
Tcrb, and Tcra knockout animals were obtained from the Jackson Laboratory,
and B6.SJL (CD45.1) was obtained from the National Cancer Institute. 5- to 8-
week-old Foxp3gfp mice were used in all instances where Foxp3 protein ex-
pression is evaluated. Animals were housed in a specific pathogen-free animal
facility at Washington University and were used according to protocols ap-
proved by the Institutional Animal Care and Use Committee.
Reagents
Monoclonal antibodies were purchased from eBioscience (San Diego, CA) and
Becton Dickenson (San Jose, CA). IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 were
obtained from Peprotech (Rocky Hill, NJ). JAK inhibitor I was purchased from
Calbiochem (San Diego, CA). CFSE and DDAO-SE were purchased from Invi-
trogen (Carlsbad, CA). Recombinant human TGF-b and anti-TGF-b (1D11) was
obtained from R&D Systems (Minneapolis, MN).
Cell Purification
CD8+ thymocytes from Foxp3gfp mice were labeled with biotinylated CD8 an-
tibody (eBioscience) and anti-biotin microbeads (Miltenyi Biotech, Auburn,
CA), and then depleted by autoMACS magnetic bead separation (Miltenyi). Re-
maining cells were stained with directly conjugated fluorescent antibodies for
CD4, CD8, CD25, and GITR (if indicated) and sorted by flow cytometry with
a FACSAria (Becton Dickenson). Other protocols, such as magnetic bead se-
lection for CD25hi thymocytes, did not increase the efficiency of this process.
Typical yield from one thymus was on the order of 5 3 104 cells.
Cell Culture
Unless otherwise stated, FACS purified thymocytes (5 3 103) were cultured
with or without 5 U/ml human IL-2 in 96-well round bottom plates. Murine
IL-7 (5 ng/ml) was also added to promote cell survival (Figure S7). Foxp3 ex-
pression was analyzed at 24 hr by flow cytometry with a FACSCanto (Becton
Dickenson). This amount of human IL-2 is approximately equivalent to 1 ng/ml
or 58.1 pM recombinant murine IL-2 as assayed by Foxp3 induction in CD25hi
cells and would be expected to saturate approximately 90% of high-affinity IL-
2Rabg receptors. IL-7 (up to 100 ng/ml) in the absence of IL-2 did not increase
Foxp3 induction in CD25lo and CD25hi cells (Figure 4B and data not shown).
Intracellular Phospho-STAT5 Staining
Phospho-STAT5 (pSTAT5) was detected as described (Van De Wiele et al.,
2004). Cells were incubated in serum-free DMEM at 1 3 106 cells/ml for
10 min at 37C, then stimulated with either human IL-2 (1000 U/ml) or murine
IL-7 (100 ng/ml) for 20 min. Cells were fixed for 15 min at room temperature by
1.5% paraformaldehyde, then washed and resuspended in 100 ml of PBS. To
permeabilize the cells, 1 ml of ice-cold methanol was added to the cells while
vortexing. After 20 min at 4C, cells were washed once with PBS and then
blocked with 10% calf serum for 15 min at room temperature. Cells were
washed and stained in Reagent B (Fix Perm kit, Invitrogen) with Alexa 647-
conjugated anti-pSTAT5 for 1 hr at room temperature. Cells were washed
three times with 1% BSA in PBS and analyzed by flow cytometry with
a FACSAria.
Supplemental Data
Eight supplemental figures are available at http://www.immunity.com/cgi/
content/full/28/1/100/DC1/.Immunity 28, 100–111, January 2008 ª2008 Elsevier Inc. 109
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